Related references
Note: Only part of the references are listed.Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
Romain-David Seban et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes
T. M. Morgan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies
Didier Debieuvre et al.
BULLETIN DU CANCER (2019)
Prognostic significance of metabolic parameters measured by 18F-FDG PET/CT in limited-stage small-cell lung carcinoma
Hyun Chang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Prognostic Significance of 18F-FDG PET/CT Metabolic Parameters and Tumor Galectin-1 Expression in Patients With Surgically Resected Lung Adenocarcinoma
Hongna Zheng et al.
CLINICAL LUNG CANCER (2019)
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis
Xiao Liu et al.
SCIENCE ADVANCES (2019)
CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients
Yukun Sun et al.
EBIOMEDICINE (2019)
Circulating Tumor Cells: Overview and Opportunities in Cytology
Kaitlin E. Sundling et al.
ADVANCES IN ANATOMIC PATHOLOGY (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
Xiao-Hui Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Circulating tumor cells count as a predictor of survival in lung cancer
Konstantinos Syrigos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
Davina Gale et al.
PLOS ONE (2018)
Clinical usefulness of 18F-FDG PET/CT for the detection of distant metastases in patients with non-small cell lung cancer at initial staging: a meta-analysis
Binbin Yu et al.
Cancer Management and Research (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma
Jing Zhang et al.
BMC CANCER (2018)
Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer
Asha Kandathil et al.
RADIOGRAPHICS (2018)
Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis
Jinxuan Hou et al.
ONCOTARGETS AND THERAPY (2018)
Metabolic tumor burden quantified on [18F]FDG PET/CT improves TNM staging of lung cancer patients
Paula Lapa et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Pharmacological management of relapsed/refractory NSCLC with chemical drugs
Niki Karachaliou et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Circulating tumor cells: clinical validity and utility
Luc Cabel et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients
Yecai Huang et al.
MEDICINE (2017)
Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients
Shinsaku Togo et al.
ONCOTARGET (2017)
Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer
G. Milaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer
Jia Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection
Clara Bayarri-Lara et al.
PLOS ONE (2016)
Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
M. Mego et al.
BMC CANCER (2015)
The detection of EpCAM+ and EpCAM- circulating tumor cells
Sanne de Wit et al.
SCIENTIFIC REPORTS (2015)
Epithelial-Mesenchymal Transitioned Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli et al.
CLINICAL CANCER RESEARCH (2015)
The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells
Huiying Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
The Clinical Impact of the Sum of the Maximum Standardized Uptake Value on the Pretreatment with 18F-FDG-PET/CT in Small-Cell Lung Cancer
Se-Il Go et al.
ONCOLOGY (2014)
Prognostic Predictive Value of Total Lesion Glycolysis From 18F-FDG PET/CT in Post-Surgical Patients With Epithelial Ovarian Cancer
Shanshan Liao et al.
CLINICAL NUCLEAR MEDICINE (2013)
Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on 18F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma
Choon-Young Kim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci et al.
LANCET ONCOLOGY (2012)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Novel Platform for Detection of CK+ and CK- CTCs
Chad V. Pecot et al.
CANCER DISCOVERY (2011)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Share Paper
